Mona I. Churchwell
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: University of Southern California (2007); Roswell Park Comprehensive Cancer Center (2008); National Institutes of Health (2005); United States Food and Drug Administration (1993–2020); University of British Columbia (1996); University of Illinois Urbana-Champaign (2005); University of Rhode Island (2003); Jefferson Community and Technical College (2010); National Institute of Environmental Health Sciences (2000); Orszagos Kornyezetegeszsegugyi Intezet (1998–2005); National Cancer Institute (1998–2005); National Center for Epidemiology (2005)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mona I. Churchwell's research focuses on the toxicokinetics and toxicological effects of chemical compounds, particularly in the context of maternal health and development. Her work investigates how substances are absorbed, distributed, metabolized, and excreted by the body, and the potential health consequences. A recent publication examined the toxicokinetics of metabolites from a C6 polyfluorinated compound in pregnant and nonpregnant rats following oral exposure to the parent compound. Churchwell's scholarship is recognized by a high h-index of 49 and over 6,800 citations across 114 publications, designating her as a highly cited researcher. She collaborates with colleagues at the National Center for Toxicological Research, including Volodymyr Tryndyak, Frederick A. Beland, Michelle M. Vanlandingham, and Daniel R. Doerge.
Metrics
- h-index: 50
- Publications: 114
- Citations: 6,949
Selected Publications
-
Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound (2023)
-
Reduction by, ligand exchange among, and covalent binding to glutathione and cellular thiols link metabolism and disposition of dietary arsenic species with toxicity (2020)
-
<i>In vivo</i> localization and postmortem stability of benzo[<i>a</i>]pyrene‐DNA adducts (2019)
-
A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results (2019)
-
Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans (2019)
-
Genotoxic and Epigenotoxic Alterations in the Lung and Liver of Mice Induced by Acrylamide: A 28 Day Drinking Water Study (2019)
-
Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: Total estrogenicity calculations accounting for competitive protein and receptor binding and potency (2018)
-
Acrylamide Production in Autoclaved Rodent Feed (2018)
-
Effect of aflatoxin B1, benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells (2018)
-
Abstract 3088: Deciphering components of mutational signatures arising from carcinogen co-exposures: A genome-scale experimental approach (2018)
-
Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women I: Serum levels, variability and the basis for urinary biomonitoring of serum estrogenicity (2018)
-
Experimental analysis of exome-scale mutational signature of glycidamide, the reactive metabolite of acrylamide (2018)
-
Metabolism and disposition of arsenic species from controlled oral dosing with sodium arsenite in adult female CD-1 mice. I. Pilot study to determine dosing, analytical measurements, and sampling strategies (2017)
-
Metabolism and pharmacokinetics of zearalenone following oral and intravenous administration in juvenile female pigs (2017)
-
Urine and serum biomonitoring of exposure to environmental estrogens II: Soy isoflavones and zearalenone in pregnant women (2016)
Collaboration Network
Top Collaborators
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
- Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound
Similar Researchers
Based on overlapping research topics